Ekso Bionics (EKSO) Reports In-Line Q2 EPS

Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.15 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• JPMorgan Upgrades Cholamandalam Investment and Finance (CIFC:IN) to Overweight
• JPMorgan Upgrades Antofagasta Plc. (ANTO:LN) (ANFGF) to Overweight
• UBS Upgrades Charoen Pokphand Foods (CPF:TB) to Buy